UnitedHealth Group (NYSE:UNH) released its quarterly earnings data on Tuesday. The healthcare conglomerate reported $2.52 EPS for the quarter, beating the consensus estimate of $2.39 by $0.13, MarketWatch Earnings reports. The company had revenue of $65.47 billion during the quarter, compared to the consensus estimate of $64.98 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The firm’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.90 EPS.
UNH stock traded up $4.16 during midday trading on Thursday, reaching $355.00. The company had a trading volume of 3,468,401 shares, compared to its average volume of 3,373,037. The company has a market capitalization of $336.83 billion, a price-to-earnings ratio of 20.43, a price-to-earnings-growth ratio of 1.55 and a beta of 0.74. The stock has a 50 day moving average price of $347.45 and a 200-day moving average price of $324.89. UnitedHealth Group has a 1-year low of $187.72 and a 1-year high of $367.95. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82.
Several equities research analysts have recently commented on UNH shares. Royal Bank of Canada increased their price objective on UnitedHealth Group from $384.00 to $389.00 and gave the company an “outperform” rating in a report on Thursday, October 15th. BMO Capital Markets increased their price target on UnitedHealth Group from $385.00 to $395.00 and gave the company a “market perform” rating in a research note on Wednesday, December 2nd. They noted that the move was a valuation call. Bank of America restated a “buy” rating and issued a $415.00 price target on shares of UnitedHealth Group in a research note on Thursday. Stephens increased their price target on UnitedHealth Group from $355.00 to $380.00 and gave the company an “overweight” rating in a research note on Wednesday, December 2nd. Finally, Credit Suisse Group increased their price target on UnitedHealth Group from $355.00 to $395.00 and gave the company an “average” rating in a research note on Thursday, November 5th. Five investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $387.82.
In other UnitedHealth Group news, EVP Marianne D. Short sold 9,993 shares of UnitedHealth Group stock in a transaction dated Tuesday, January 5th. The stock was sold at an average price of $348.69, for a total value of $3,484,459.17. Also, Director Richard T. Burke sold 7,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, December 8th. The shares were sold at an average price of $349.78, for a total value of $2,448,460.00. Following the completion of the transaction, the director now owns 159,487 shares in the company, valued at approximately $55,785,362.86. The disclosure for this sale can be found here. In the last ninety days, insiders sold 130,253 shares of company stock valued at $43,485,730. 0.80% of the stock is owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Read More: What is a good dividend yield?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.